| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/30/1997 | EP0785792A1 Treatment of ovarian estrogen dependent conditions |
| 07/30/1997 | EP0785788A1 Use of cck-b receptor antagonists for the treatment of sleep disorders |
| 07/30/1997 | EP0785784A1 4-heterocyclic piperidines promote release of growth hormone |
| 07/30/1997 | EP0785713A1 Creating an aerosolized formulation of insulin |
| 07/30/1997 | EP0636146B1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 07/30/1997 | EP0547099B1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa |
| 07/30/1997 | EP0481089B1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus |
| 07/30/1997 | EP0476044B1 Use of IGF1 or IGF2 for the manufacture of a medicament in the treatment of amyotrophic lateral sclerosis |
| 07/30/1997 | CN1155904A LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/30/1997 | CN1155903A T cell antigen receptor V region proteins and methods of preparation thereof |
| 07/30/1997 | CN1155549A Non-densatured extraction of medical collagen protein and denatured application |
| 07/30/1997 | CN1155437A Composition extracted from collagen and preparation thereof |
| 07/29/1997 | US5652369 Amino acid derivatives |
| 07/29/1997 | US5652357 Nucleic acids for the detection of the Bak polymorphism in human platelet membrane glycoprotein IIb |
| 07/29/1997 | US5652356 Inverted chimeric and hybrid oligonucleotides |
| 07/29/1997 | US5652353 DNAs encoding tumor necrosis factor-α muteins |
| 07/29/1997 | US5652343 Method for purification of L-selectin ligands |
| 07/29/1997 | US5652342 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 07/29/1997 | US5652339 Method of producing reconstituted lipoproteins |
| 07/29/1997 | US5652338 Neutrophil chemotactic factor |
| 07/29/1997 | US5652337 OP-3-induced morphogenesis |
| 07/29/1997 | US5652334 Method for design of substances that enhance memory and improve the quality of life |
| 07/29/1997 | US5652333 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 07/29/1997 | US5652332 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/29/1997 | US5652257 Anticarcinogenic |
| 07/29/1997 | US5652235 Method of using spiro piperidines to promote the release of growth hormone |
| 07/29/1997 | US5652233 Carbapenicillins |
| 07/29/1997 | US5652224 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652222 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides |
| 07/29/1997 | US5652220 Containing copolymer of lactic acid and glycolic acid and active agent in water in oil emulsion |
| 07/29/1997 | US5652219 Hemoregulatory peptides |
| 07/29/1997 | US5652217 Nucleotide sequence from staphylococcus aureus which codes for protein or polypeptide |
| 07/29/1997 | US5652216 Pharmaceutical preparation |
| 07/29/1997 | US5652214 Treating disorders by application of insulin-like growth factors and analogs |
| 07/29/1997 | US5652213 Cyclic peptide antifungal agents |
| 07/29/1997 | US5652212 Cyclosporin galenic forms |
| 07/29/1997 | US5652211 Treatment of septic shock |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652209 Administering transforming growth factor |
| 07/29/1997 | US5652138 Immunoreacts with human immunodeficiency virus glycoprotein |
| 07/29/1997 | US5652130 Retroviral vectors expressing tumor necrosis factor (TNF) |
| 07/29/1997 | US5652123 Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 07/29/1997 | US5652122 Nucleic acids encoding and methods of making tat-derived transport polypeptides |
| 07/29/1997 | US5652118 Nucleic acid encoding a novel morphogenic protein, OP-3 |
| 07/29/1997 | US5652117 Human transcription factor IIA |
| 07/29/1997 | US5652114 Diagnostic immunoassay methods using monoclonal antibody F36/22 which is specific for human breast carcinoma cells |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |
| 07/29/1997 | US5652112 Assay for type I collagen carboxy-terminal telopeptide analytes |
| 07/29/1997 | US5652111 System for detecting compounds that are potassium channel modulators |
| 07/29/1997 | US5652110 Antibodies to αvβ3 integrin |
| 07/29/1997 | US5652109 Antitumor agents; medical diagnosis |
| 07/29/1997 | US5652100 Stably transfected rodent fibroblast cell lines expressing human GABA-A -receptors |
| 07/29/1997 | US5652095 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/29/1997 | US5652094 Nucleozymes |
| 07/29/1997 | US5651993 Irradiating leukocyte mixture in psoralen presence; reacting with peptide antigens |
| 07/29/1997 | US5651986 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 07/29/1997 | US5651982 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 07/29/1997 | US5651980 Methods of use of uncoated gel particles |
| 07/29/1997 | US5651979 Apparatus and method for delivering a biologically active compound into a biological environment |
| 07/29/1997 | US5651972 Use of recombinant swine poxvirus as a live vaccine vector |
| 07/29/1997 | US5651970 Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics |
| 07/29/1997 | US5651969 Enhancing neurite outgrowth and improving nerve regeneration |
| 07/29/1997 | US5651967 Method of alleviating gastrointestinal distress by ingesting beta-fructofuranosidase |
| 07/29/1997 | US5651966 Wound healing agents |
| 07/29/1997 | US5651964 Transfection, gene expression, antitumor, anticarcinogenic |
| 07/29/1997 | US5651963 Heterodimers forms of CSF-1 and pharmaceutical compositions thereof |
| 07/29/1997 | US5651957 Administering lantibiotic |
| 07/29/1997 | CA1339189C Amblyommin, a new active substance for anticoagulant therapy |
| 07/29/1997 | CA1339185C Lymphocyte inhibition by hla peptides |
| 07/29/1997 | CA1339111C Antiviral agent |
| 07/29/1997 | CA1339106C Hirullin polypeptides having anticoagulant activity |
| 07/29/1997 | CA1339105C Modified proteins |
| 07/29/1997 | CA1339104C Hirudin derivative |
| 07/29/1997 | CA1339098C Characterization and detection of sequences associated with autoimmune diseases |
| 07/29/1997 | CA1339071C Thrombus control agent |
| 07/29/1997 | CA1339070C Treatment of diseases associated with cysteine deficiency |
| 07/27/1997 | CA2168194A1 Ifn-omega as anti hiv-agent |
| 07/24/1997 | WO1997026535A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026353A1 ALANYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026352A1 STAPHYLOCOCCUS AUREUS SERYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026350A1 STAPHYLOCOCCUS AUREUS METHIONYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026348A1 ASPARAGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026341A1 CYSTEINYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026340A1 STAPHYLOCOCCUS AUREUS GLYCYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026338A1 Staphylococcus aureus wcuh29 spoiiie protein |
| 07/24/1997 | WO1997026337A1 Methods for delivering dna to muscle cells using recombinant adeno-associated virus virions |